BioSpace News Archive

Orchard Laboratories, headquartered in West Bloomfield, Mich. (7901 Orchard Lake Road, Suite 100) is the first private laboratory in Michigan to provide rapid testing for COVID-19 with new, state-of-the art equipment using the Emergency Use Authorization (EUA) protocol for the ThermoFisher 7500DX Platform.

Versant Health, a leading national managed eye health and vision plan company, is proud to welcome Kristyn Parzynski, as its new Vice President, Labor Sales.

AliveCor, the leader in AI-based, personal ECG technology, today announced it will offer a QTc measurement service on ECGs from AliveCor’s KardiaMobile 6L, the world’s only FDA-cleared six-lead personal ECG.

Origin, the developer of the leading open platform for additive mass manufacturing, is an instrumental additive manufacturing leader collaborating with Beth Israel Deaconess Medical Center (BIDMC) to find a better solution for manufacturing COVID-19 test swabs.

180,000 new claims processed for telephone and virtual visits in March, along with 50,000 new claims for COVID-19 testing and care

Allied Motion Technologies Inc. (Nasdaq: AMOT) manufactures and delivers critical motion control components, including electronic drives, motors and control assemblies to manufacturers of medical equipment including respirators, ventilators, infusion pumps, medical fluid pumps and other breathing assist equipment required to care for patients with respiratory issues including the coronavirus.

BERG, a clinical-stage biotech company that uses artificial intelligence (AI) to research diseases and develop innovative treatments, has been awarded a spot in Frost & Sullivan’s first-ever Frost Radar™ AI in Drug Discovery report in the pharmaceutical industry.

Many processes that generate electricity also produce heat, a potent energy resource that often goes untapped everywhere from factories to vehicles to power plants. An innovative system currently being developed at the U.S. Department of Energy’s (DOE) Argonne National Laboratory can quickly store heat and release it for use when needed, surpassing conventional storage options in both flexibility and efficiency

BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer, today announced that the Phase 3 trial evaluating its anti-PD-1 antibody tislelizumab in combination with pemetrexed and platinum chemotherapy for the first-line treatment of patients with non-squamous non-small cell lung cancer

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for an additional molecular diagnostic test for COVID-19 that can return results in two to three hours.